IE35937L - Local anaesthetic composition - Google Patents

Local anaesthetic composition

Info

Publication number
IE35937L
IE35937L IE711611A IE161171A IE35937L IE 35937 L IE35937 L IE 35937L IE 711611 A IE711611 A IE 711611A IE 161171 A IE161171 A IE 161171A IE 35937 L IE35937 L IE 35937L
Authority
IE
Ireland
Prior art keywords
local anaesthetic
anaesthetic composition
composition
local
anaesthetic
Prior art date
Application number
IE711611A
Other versions
IE35937B1 (en
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of IE35937L publication Critical patent/IE35937L/en
Publication of IE35937B1 publication Critical patent/IE35937B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE1611/71A 1971-01-26 1971-12-20 Local anaesthetic composition IE35937B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (2)

Publication Number Publication Date
IE35937L true IE35937L (en) 1972-07-26
IE35937B1 IE35937B1 (en) 1976-07-07

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
IE1611/71A IE35937B1 (en) 1971-01-26 1971-12-20 Local anaesthetic composition
IE1610/71A IE35910B1 (en) 1971-01-26 1971-12-20 Pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE1610/71A IE35910B1 (en) 1971-01-26 1971-12-20 Pharmaceutical composition

Country Status (18)

Country Link
AT (2) AT310938B (en)
AU (1) AU465875B2 (en)
BE (2) BE776769A (en)
BR (2) BR7108428D0 (en)
CA (2) CA986012A (en)
DD (2) DD96400A5 (en)
DE (2) DE2163055A1 (en)
DK (2) DK130389B (en)
ES (2) ES398108A1 (en)
FR (2) FR2123278B1 (en)
GB (1) GB1370904A (en)
HU (2) HU162185B (en)
IE (2) IE35937B1 (en)
LU (1) LU64664A1 (en)
NL (2) NL7117401A (en)
NO (2) NO135892C (en)
SE (2) SE391127B (en)
ZA (2) ZA718327B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
AU6883798A (en) * 1997-04-02 1998-10-22 Regents Of The University Of California, The Method of anesthesia
AU7389098A (en) 1997-05-16 1998-12-08 Brigham And Women's Hospital Local anesthetic formulations
WO2007110221A1 (en) 2006-03-27 2007-10-04 Wex Pharmaceuticals Inc. Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
RU2015143665A (en) 2013-03-15 2017-04-27 Дзе Чилдрен'З Медикал Сентер Корпорейшн COMBINED DRUGS OF NEOSAXITOXIN FOR PROLONGED LOCAL ANESTHESIA

Also Published As

Publication number Publication date
AU465875B2 (en) 1975-10-09
LU64664A1 (en) 1972-08-23
DE2163054B2 (en) 1978-06-01
FR2123278B1 (en) 1975-08-01
HU162185B (en) 1973-01-29
NO135892B (en) 1977-03-14
IE35910B1 (en) 1976-06-23
NO135891C (en) 1978-05-16
IE35937B1 (en) 1976-07-07
BE776768A (en) 1972-06-16
NL7117404A (en) 1972-07-28
ZA718327B (en) 1972-09-27
GB1370904A (en) 1974-10-16
NO135892C (en) 1978-05-16
DD96400A5 (en) 1973-03-20
CA983850A (en) 1976-02-17
DE2163054C3 (en) 1979-02-01
HU162347B (en) 1973-02-28
DE2163055A1 (en) 1972-10-12
SE391127B (en) 1977-02-07
CA986012A (en) 1976-03-23
FR2123277B1 (en) 1975-06-13
NO135891B (en) 1977-03-14
DE2163054A1 (en) 1974-05-02
BR7108428D0 (en) 1973-06-14
IE35910L (en) 1972-07-26
BR7108429D0 (en) 1973-06-14
ZA718326B (en) 1972-09-27
NL7117401A (en) 1972-07-28
DK131606C (en) 1976-01-12
FR2123278A1 (en) 1972-09-08
ES398108A1 (en) 1975-03-01
AT310938B (en) 1973-10-25
ES398109A1 (en) 1975-03-16
DD96144A5 (en) 1973-03-12
DK130389B (en) 1975-02-17
AU3710071A (en) 1973-06-28
AT310939B (en) 1973-10-25
SE391286B (en) 1977-02-14
DK131606B (en) 1975-08-11
FR2123277A1 (en) 1972-09-08
DK130389C (en) 1975-07-14
BE776769A (en) 1972-06-16
AU3710171A (en) 1973-06-28

Similar Documents

Publication Publication Date Title
IE36891L (en) Coronary-dilating composition
AU5119173A (en) Composition
EG10723A (en) Substituted para-menthanes
ZA727741B (en) Thermofomable compositions
HK57478A (en) Photopolymerisable composition
GB1372932A (en) Anti-caries compositions
PH10909A (en) Esterocyclic compounds and compositions thereof
ZA721353B (en) Polyamide-diazo resin composition
ZA724552B (en) Antiseborrhoeic compositions
ZA721446B (en) Substituted 3-benzylpyridines
CY958A (en) Plaster composition
GB1393014A (en) Polyurethane-tar compositions
ZA721359B (en) Substituted thiadiazolidine-diones
IE35937L (en) Local anaesthetic composition
IL39336A0 (en) Substituted 2-anilinobenzoxazoles
JPS5494024A (en) Photosensitive composition
ZA722089B (en) Substituted chlorocarbonylureas
GB1391562A (en) Resinous composition
GB1370905A (en) Local anaesthetic composition
GB1367202A (en) Reflex-reflecting compositions
IL38799A0 (en) Substituted phenylthiocarbamates
ZA717795B (en) Anesthetic
CY755A (en) Therapeutic composition
YU282572A (en) Kuciste i poklopac kucista
IL39333A0 (en) Substituted benzimidazolecarbamates